Childhood Depression: Pharmacological Therapy/Treatment (Pharmacotherapy of Childhood Depression)

Journal of Clinical Child and Adolescent Psychology

Volumn 30, Issue 1, 2001, Pages 88-97

  Wagner, Karen Dineen ^b   Ambrosini, Paul J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; DEPRESSIVE DISORDER; HUMANS; MODELS, PSYCHOLOGICAL; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0035288143     PISSN: 15374416     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15374424JCCP3001_10     Document Type: Article

References (54)

1. Achenbach, T. M. (1993). Manual for the Child Behavior Checklist 4-18. Burlington, VT: Associates in Psychiatry.
2. Ambrosini, P. J., Bianchi, M. D., Metz, C., & Rabinovich, H. (1994). Evaluating clinical response of open nortriptyline pharmacotherapy in adolescent major depression. Journal of Child and Adolescent Psychopharmacology, 4, 233-244.
3. Ambrosini, P. J., Metz, C., Bianchi, M. D., Rabinovich, H., & Undie, A. (1991). Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 51-57.
4. Ambrosini, P. J., Wagner, K. D., Biederman, J., Glick, I., Tan, C., Elia, J., Hebeler, J. R., Rabinovich, H., Lock, J., & Geller, D. (1999). Multi-center open label sertraline study in adolescent outpatients with major depression. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 566-572.
5. American Academy of Child and Adolescent Psychiatry. (1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 63S-83S.
6. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd. ed.).Washington, DC: Author.
7. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders 3rd ed., rev.). Washington, DC: Author.
8. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
9. Angold, A. (1997). The nosological status of depression in children and adolescents. In T. A. Widiger, A. J. Frances, H. A. Pincus, R. Ross, M. B. First, & W. Davis (Eds.), Sourcebook for DSM-IV (Vol. 3, pp. 265-278). Washington, DC: American Psychiatric Association.
10. Angold, A., & Costello, E. J. (1993). Depressive comorbidity in children and adolescents: Empirical, theoretical, and methodological issues. American Journal of Psychiatry, 150, 1779-1791.
11. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
12. Birmaher, B., Waterman, G. S., Ryan, N. D., Perel, J., McNabb, J., Balach, L., Beaudry, M. B., Nasr, F. N., Karambelkar, J., Elterich, G., Quintana, H., Williamson, D. E., & Rao, U. (1998). Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 527-535.
13. Carlson, G. A., Kashani, J. H., de Fatima Thomas, M., Vaidya, A., & Daniel, A. E. (1987). Comparison of two structured interviews on a psychiatrically hospitalized population of children. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 645-648.
14. Chambers, W. J., Puig-Antich, J., Hirsch, M., Paez, P., Ambrosini, P. J., Tabrizi, M. A., & Davies, M. (1985). The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Archives of General Psychiatry, 42, 696-702.
15. Conners, C. K. (1992). Methodology of antidepressant drug trials for treating depression in adolescents. Journal of Child and Adolescent Psychopharmacology, 2, 11-22.
16. Demitrack, M. A., Faries, D., Herrera, J. M., DeBrota, D., & Potter, W. Z. (1998). The problem of measurement error in multisite clinical trials. Psychopharmacology Bulletin, 34, 19-24.
17. Emslie, G. J., Rush, A. J., Weinberg, W. A., Gullion, C. M., Rintelmann, J., & Hughes, C. W. (1997a). Recurrence of major depressive disorder in hospitalized children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 785-792.
18. Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., & Rintelmann, J. (1997b). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
19. Geller, B., Cooper, T. B., Graham, D. L., Fetner, H. H., Marsteller, F. A., & Wells, J. M. (1992). Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 34-44.
20. Geller, B., Cooper, T. B., Graham, D. L., Marsteller, F. A., & Bryant, D. M. (1990). Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacology Bulletin, 26, 85-90.
21. Goldman-Rakic, C. P., & Brown, R. M. (1982). Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Developmental Brain Research, 4, 339-349.
22. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry, 23, 64-71.
23. Hammen, C., Rudolph, K., Weisz, J., Rao, U., & Burge, D. (1999). The context of depression in clinic-referred youth: Neglected areas in treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 64-71.
24. Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995). Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis. British Medical Journal, 310, 897-901.
25. Herjanic, B., & Reich, W. (1982). Development of a structured psychiatric interview for children: Agreement between child and parent on individual symptoms. Journal of Abnormal Child Psychology, 10, 307-324.
26. Hughes, C. W., Preskorn, S. H., Weller, E., Weller, R., Hassanein, R., & Tucker, S. (1990). The effect of concomitant disorders in childhood depression on predicting treatment response. Psychopharmacology Bulletin, 26, 235-238.
27. Kashani, J. H., Shekim, W. O., & Reid, J. C. (1984). Amitriptyline in children with major depressive disorder: A double-blind cross-over pilot study. Journal of the American Academy of Child Psychiatry, 23, 348-351.
28. Keller, M. B., Ryan, N. D., Birmaher, B., Klein, R. G., Strober, M., Wagner, K. D., & Weller, E. B. (1998, May). Paroxetine and imipramine in the treatment of adolescent depression. Paper presented at the American Psychiatric Association, Toronto, Canada.
29. Kovacs, M. (1985). The Children's Depression Inventory (CDI). Psychopharmacology Bulletin, 21, 995-998.
30. Kovacs, M. (1996). Presentation and course of major depressive disorder during childhood and later years of the life span. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 705-715.
31. Kramer, A. D., & Feiguine, R. J. (1981). Clinical effects of amitriptyline in adolescent depression. A pilot study. Journal of the American Academy of Child Psychiatry, 20, 636-644.
32. Kutcher, S., Boulos, C., Ward, B., Marton, P., Simeon, J., Ferguson, H. B., Szalai, J., Katic, M., Roberts, N., & Dubois, C. (1994). Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 686-694.
33. Kye, C., & Ryan, N. (1995). Pharmacologic treatment of child and adolescent depression. Child and Adolescent Psychiatric Clinics of North America, 4, 261-281.
34. Kye, C. H., Waterman, G. S., Ryan, N. D., Birmaher, B., Williamson, D. E., Iyengar, S., & Dachille, S. (1996). A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1139-1144.
35. Mandoki, M. W., Tapia, M. R., Tapia, M. A., Sumner, G. S., & Parker, J. L. (1997). Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacology Bulletin, 33, 149-154.
36. McCauley, E., Myers, K., Mitchell, J., Calderon, R., Schloredt, K., & Treder, R. (1993). Depression in young people: Initial presentation and clinical course. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 714-722.
37. McConville, B., Ambrosini, P. J., Somoza, S., Bianchi, M. D., & Minnery, K. L. (1995, October). Optimal cut-off points for depression rating scales in adolescent depression. Paper presented at the American Academy of Child and Adolescent Psychiatry, New Orleans, LA.
38. McLaughlin, J. L., Ambrosini, P. J., Fallon, T., Bianchi, M. D., & Metz, C. (1997, October). Validity parameters of the Children's Depression Inventory in pre-adolescent outpatients. Paper presented at the American Academy of Child and Adolescent Psychiatry, Toronto, Canada.
39. Murrin, L. C., Gibbens, D. L., & Ferrer, J. R. (1985). Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain - An autoradiographic study. Brain Research, 355, 91-109.
40. Overall, J. E., & Pfefferbaum, B. (1982). The Brief Psychiatric Rating Scale for Children. Psychopharmacology Bulletin, 18, 10-16.
41. Petti, T. A., & Law, W. D. (1982). Imipramine treatment of depressed children: A double-blind pilot study. Journal of Clinical Psychopharmacology, 2, 107-110.
42. Poznanski, E. O., Cook, S. C., & Carroll, B. J. (1979). A depression rating scale for children. Pediatrics, 64, 442-450.
43. Poznanski, E. O., Grossman, J. A., Buchsbaum, Y., Banegas, M., Freeman, L., & Gibbons, R. (1984). Preliminary studies of the reliability and validity of the children's depression rating scale. Journal of the American Academy of Child Psychiatry, 23, 191-197.
44. Puig-Antich, J., Perel, J. M., Lupatkin, W., Chambers, W. J., Tabrizi, M. A., King, J., Goetz, R., Davies, M., & Stiller, R. L. (1987). Imipramine in prepubertal major depressive disorders. Archives of General Psychiatry, 44, 81-89.
45. Rao, U., Weissman, M. M., Martin, J. A., & Hammond, R. W. (1993). Childhood depression and risk of suicide: A preliminary report of a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 21-27.
46. Ryan, N. D., Puig-Antich, J., Cooper, T., Rabinovich, H., Ambrosini, P., Davies, M., King, J., Torres, D., & Fried, J. (1986). Imipramine in adolescent major depression: Plasma level and clinical response. Acta Psychiatrica Scandinavica, 73, 275-288.
47. Shaffer, D., Gould, M. S., Brasic, J., Ambrosini, P., Fisher, P., Bird, H., & Aluwahlia, S. (1983). A children's global assessment scale (CGAS). Archives ofGeneral Psychiatry, 40, 1228-1231.
48. Simeon, J. G., Dinicola, V. F., Ferguson, H. B., & Copping, W. (1990). Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuropsychopharmacology and Biologic Psychiatry, 14, 791-795.
49. Simeon, J. G., Ferguson, H. B., Copping, W. M., & Dinicola, V. F. (1988, October). Fluoxetine effects in adolescent depression. Paper presented at the American Academy of Child and Adolescent Psychiatry, Seattle, WA.
50. Spitzer, R. L., Endicott, J., & Robins, E. (1978). Research diagnostic criteria: Rationale and reliability. Archives of General Psychiatry, 35, 773-782.
51. Stahl, S. M. (1996). Essential psychopharmacology: Neuroscientific basis and practical applications. New York: Cambridge University Press.
52. Stahl, S. M. (1998). Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. Journal of Clinical Psychiatry, 59, 5-14.
53. Weissman, M. M., Wolk, S., Goldstein, R. B., Moreau, D., Adams, P., Greenwald, S., Klier, C. M., Ryan, N. D., Dahl, R. E., & Wickramaratne, P. (1999). Depressed adolescents grown up. Journal of the American Medical Association, 281, 1707-1713.
54. Williamson, D. E., Ryan, N. D., Birmaher, B., Dahl, R. E., Kaufman, J., Rao, U., & Puig-Antich, J. (1995). A case-control family history study of depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1596-1607.